Search

everythinglearnresearchcommunity

for

Search:↓

The method effectively mimics shaving damage on skin for testing skincare products.

COVID-19 reinfection may trigger alopecia areata.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

PRP therapy shows promise in healing and tissue repair across various medical fields but needs more research for standardization and optimization.

Activins and follistatins, part of the TGFβ family, are crucial for hair follicle development and skin health, affecting growth, repair, and the hair cycle.

Type I interferons play a key role in the development of various skin diseases.

IL-1β inhibits human hair follicle growth.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Topical treatments led to hair regrowth in a man with linear morphea.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Early hair loss may indicate risk of insulin resistance.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Prolactin may affect hair growth differently based on gender and scalp area.

Regulatory T cells are essential for normal and improved wound healing in mice.

Leptin helps start the growth phase of hair.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Finasteride causes reduced tear flow and severe eye inflammation.

Ruxolitinib treatment may cause eyelash growth.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.